Services
Demonstrating the value of medicines in rare diseases is complex; the burden of disease is poorly documented and lack of disease specific therapeutic options which means the decision context is often unclear.
The bedrock that underpins our approach is developing a deep understanding of the decision process whilst ensuring development of the value strategy remains aligned with commercial and clinical objectives.
Our value and access offerings include:
Value & Access
Value strategy development
Value proposition development
Value dossiers
Value demonstration
Budget impact models
Pre-launch pricing strategy
Virtual Delphi Panels
HTAs, pricing and reimbursement submissions